Abstract
Despite impaired quality of life, limited studies have evaluated health utility among patients with newly diagnosed acute myeloid leukemia (ND-AML) who are ineligible for intensive chemotherapy. The Viale-A and Viale-C studies are the only trials that collected EuroQoL 5-Dimension (EQ-5D) data for patients in different health states. The study aims to estimate the health state utility values among this population across multiple countries.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
